EX-1.2: PRICING AGREEMENT

Exhibit 1.2

PRICING AGREEMENT

October 8, 2008

Credit Suisse Securities (USA) LLC
As Representatives of the several Underwriters
named in Schedule I hereto

c/o Credit Suisse Securities (USA) LLC
Eleven Madison Avenue
New York, New York 10010-3629

Ladies and Gentlemen:

     MetLife, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein (this “Agreement”) and in the Underwriting Agreement, dated October 8, 2008 (the “Underwriting Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the total number of shares of the Company’s common stock, par value $0.01 per share specified in Schedule I hereto (the “Firm Securities”) at the purchase price per share specified in Schedule II hereto. In addition, the Company proposes, subject to the terms and conditions stated in this Agreement and the Underwriting Agreement, to grant to the Underwriters the option, exercisable from time to time not more than 30 days subsequent to the date of the Final Prospectus, to purchase all or less than all of the number of shares specified on Schedule II hereto as the “Optional Securities” at the purchase price per share to be paid for the Firm Securities.

     Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Agreement and the Closing Date. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein as therein defined. The Firm Securities and the Optional Securities shall be considered Securities under the Underwriting Agreement. The Representatives designated to act on behalf of the Representatives and on behalf of each of the Underwriters of the Securities pursuant to the Underwriting Agreement and the address of the Representatives are set forth at the end of Schedule II hereto.

     Subject to the terms and conditions set forth herein and in the Underwriting Agreement incorporated herein by reference, the Company agrees to issue, sell and deliver to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at the time and place and at the purchase price to the Underwriters

set forth in Schedule II hereto, the number of Firm Securities set forth opposite the name of such Underwriter in Schedule I hereto. The date of the issuance, sale and delivery of the Firm Securities is the “First Closing Date” set forth on Schedule II hereto and such date shall be considered a Closing Date under the Underwriting Agreement.

     If the Representatives give written notice to the Company at any time and from time to time not more than 30 days subsequent to the date of the Final Prospectus, then, subject to the terms and conditions set forth herein and in the Underwriting Agreement incorporated herein by reference, the Company agrees to issue and sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company the percentage of the total number of Optional Securities specified in such notice that equals the percentage set forth opposite such Underwriter’s name on Schedule I hereto (subject to adjustment by the Representatives to eliminate fractions). Optional Securities may be purchased by the Underwriters only for the purpose of covering over-allotments made in connection with the sale of the Firm Securities. No Optional Securities shall be sold or delivered unless the Firm Securities previously have been, or simultaneously are, sold and delivered. The right to purchase the Optional Securities or any portion thereof may be exercised from time to time and to the extent not previously exercised may be surrendered and terminated at any time upon notice by the Representatives to the Company. Each time for the delivery of and payment for the Optional Securities (each, an “Optional Closing Date”) may be the First Closing Date and each Optional Closing Date, if any, shall be considered a Closing Date under the Underwriting Agreement. Each Optional Closing Date shall be determined by the Representatives but shall be not later than five full business days after written notice of election to purchase Optional Securities is given.

     If the foregoing is in accordance with your understanding, please sign and return to us counterparts hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance hereof, including the provisions of the Underwriting Agreement incorporated herein by reference, shall constitute a binding agreement between each of the Underwriters and the Company. It is understood that your acceptance of this letter on behalf of each of the Underwriters is or will be pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to the Company for examination upon request, but without warranty on the part of the Representatives as to the authority of the signers thereof.

Accepted as of the date hereof
on behalf of each of the Underwriters:

CREDIT SUISSE SECURITIES (USA) LLC

By:		/s/ David M. Platter
		Name: David M. Platter
		Title: Managing Director

SCHEDULE I
TO PRICING AGREEMENT

		Number of Firm
		Securities to be				Percentage of
Underwriters		Purchased				Optional Securities
Credit Suisse Securities (USA) LLC			45,000,000				60.0	%
Merrill Lynch, Pierce, Fenner & Smith Incorporated			15,000,000				20.0	%
UBS Securities LLC			15,000,000				20.0	%
Total			75,000,000				100	%

SCHEDULE II
TO PRICING AGREEMENT

Underwriting Agreement, dated October 8, 2008

Registration Statement No. 333-147180

INITIAL PRICE TO THE PUBLIC: $26.50

PURCHASE PRICE BY UNDERWRITERS: $25.811

NUMBER OF OPTIONAL SECURITIES: 11,250,000

PARTIES TO LOCK-UP AGREEMENTS:

C. Robert Henrikson
Ruth Fattori
Steven A. Kandarian
James L. Lipscomb
Maria R. Morris
William J. Mullaney
William J. Toppeta
Lisa M. Weber
William J. Wheeler
Eduardo Castro-Wright
Burton A. Dole, Jr.
Cheryl W. Grisé
John M. Keane
Hugh B. Price
Kenton J. Sicchitano
Lulu C. Wang
James M. Kilts
William C. Steere, Jr.
Sylvia M. Burwell
R. Glenn Hubbard
David Satcher, M.D., Ph.D.

FIRST CLOSING DATE: October 15, 2008

TIME OF FIRST CLOSING: 10 A.M.

LOCATION OF FIRST CLOSING: the offices of Skadden, Arps, Slate, Meagher & Flom LLP, Four Times Square, New York, New York 10036

REPRESENTATIVES: Credit Suisse Securities (USA) LLC

ADDRESSES FOR NOTICES, ETC.:

IF TO THE REPRESENTATIVES:

Credit Suisse Securities (USA) LLC
Eleven Madison Avenue
New York, New York 10010-3629
Attention: LCD-IBD

IF TO THE COMPANY:

MetLife, Inc.
27-01 Queens Plaza North
Long Island City, New York 11101
Attention: Treasurer